Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenovirus Type-5 Vectored COVID-19 Vaccine”

3 trials

Showing 3 of 3 results

Early research (Phase 1)Study completedNCT04568811
What this trial is testing

The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine

Who this might be right for
Adenovirus Type-5 Vectored COVID-19 Vaccine
Jiangsu Province Centers for Disease Control and Prevention 89
Post-approval studies (Phase 4)Study completedNCT05313646
What this trial is testing

Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 1,050
Post-approval studies (Phase 4)UnknownNCT05373030
What this trial is testing

Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine

Who this might be right for
Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
Zhejiang Provincial Center for Disease Control and Prevention 200

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation